Status:
COMPLETED
Diagnosis and Treatment of Pheochromocytoma
Lead Sponsor:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Pheochromocytoma
Eligibility:
All Genders
Brief Summary
Pheochromocytoma is a tumor of the adrenal gland. This tumor is typically benign (not cancerous) and can be cured by surgical removal. However, pheochromocytomas produce neurohormones called cateholam...
Detailed Description
Patients suspected of having a pheochromocytoma will be studied via a series of tests in an attempt to ascertain biochemically whether or not they really have such a tumor. These procedures will inclu...
Eligibility Criteria
Patients of any age and either sex who are suspected of having a pheochromocytoma on the basis of one or more of the following: 1. hypertensive episodes in a normotensive subject, 2. abnormal levels of blood and/or urinary catecholamines or their metabolites, or 3. an otherwise unexplained abdominal mass.
Patients without any evidence of pheochromocytoma are excluded.
Key Trial Info
Start Date :
October 1 1988
Trial Type :
OBSERVATIONAL
End Date :
January 1 2001
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT00001229
Start Date
October 1 1988
End Date
January 1 2001
Last Update
March 4 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Heart, Lung and Blood Institute (NHLBI)
Bethesda, Maryland, United States, 20892